Affiliate Commerce for “cholesterol statins”
Google Trends · Automated AI Business Plan

Affiliate Commerce for “cholesterol statins”

Route consumer-intent keywords into price-comparison/shopping guides, monetized via affiliate commissions.

Source keyword cholesterol statins volume 5,000 · growth +300% · persistence: Flash trend (2 observations over 1 day) · intent: Informational (6/10) · category Health · region US · collected 07/28/2026, 12:20 AM
StatinGuide AI
9.8%
Seed 5-yr ROI (realized)
1.9%
5-yr annualized return
21%
Win rate (profitable exit)
4.2 : 1
Profit/loss ratio

Anchored on Google Trends keyword "cholesterol statins" · Auto-generated by deterministic model, not manual due diligence · Narrative prose was generated in Chinese; framework labels are localized.

Executive Summary

Executive Summary

全自动AI服务,提供个性化他汀类药物与胆固醇信息、风险解读与健康建议。

Your AI-powered Statin & Cholesterol Navigator

他汀关注激增(+300%),AI医疗问答成熟,远程健康信息需求高涨。

Seed return at a glance (realized / cash basis): Cumulative ROI of Y1 -69.0%, Y2 -43.6%, Y3 -22.8%, Y4 -5.2%, Y5 9.8%; ~1.9% 5-yr annualized; win rate (profitable exit) ~21.2%; profit/loss ratio ~4.19:1; expected MOIC ~1.10×.
Source Hot Keyword

Source Hot Keyword

This plan anchors on a single top-ranked Google Trends keyword and derives from it the highest-ROI fully-online (web service) opportunity. The table below is the full provenance snapshot of that source keyword (stored with the plan and auditable).

Source keywordcholesterol statins
Collection rank
Search volume5,000
Growth rate+300%
Trend persistencepersistence: Flash trend (2 observations over 1 day)
Commercial intentintent: Informational (6/10)
CategoryHealth
RegionUS
Collected at07/28/2026, 12:20 AM
Source tabletrending_now
Opportunity Selection

Opportunity Selection & Ranking

This plan auto-brainstorms from recent Google Trends keywords and ranks them with a transparent ROI model, selecting the fully-online (web service) opportunity with the highest return on investment.

RankOpportunityROI scoreOne-line positioning
1StatinGuide AI 5.63 全自动AI服务,提供个性化他汀类药物与胆固醇信息、风险解读与健康建议。

Supporting trend evidence (sample)

cholesterol statins · vol 5,000 · +300%
Problem

Problem

患者对他汀药物副作用、适应症、替代方案缺乏权威、个性化解读。

Solution

Solution

AI自动解读最新指南,结合用户健康数据,输出定制化风险与用药建议。

AI个性化他汀用药科普与风险评估

智能问答与副作用管理建议

自动推送最新研究与指南摘要

药物与健康数据安全整合

Market

Market Analysis

TAM: $2.1B(美国在线健康信息市场,Statista 2023)

SAM: $210M(高胆固醇患者在线自助服务,10% TAM)

SOM: $6.3M(首年目标1% SAM)

美国有超9,500万成人高胆固醇(CDC 2023);在线自助渗透率3%。

Product

Product & Service

AI个性化他汀用药科普与风险评估

智能问答与副作用管理建议

自动推送最新研究与指南摘要

药物与健康数据安全整合

Business Model

Business Model & Unit Economics

单次报告 · $19 · 个性化AI解读与建议PDF

年度会员 · $69 · 不限次数AI问答+每月新报告

单次服务边际成本<$0.50(GPT-4+云服务),毛利率>97%。

Financial metricYear 1Year 2Year 3
Active users3,84110,66921,338
Paying users100277555
Revenue (¥)¥224,640¥622,253¥1,246,752
Gross profit (¥)¥184,205¥510,247¥1,022,337
Opex (¥)¥615,707¥995,454¥1,436,106
EBITDA (¥)¥-431,502¥-485,207¥-413,769

Unit economics: LTV $768 · effective CAC $224 · LTV/CAC 3.42:1 (healthy ≥3:1, credible cap 6:1) · payback 10.53 months · avg lifetime 3 years.

Year-3 indicative exit EV ≈ ¥0 (at 4× SDE/EBITDA, online-asset M&A benchmark).

This table is computed by the deterministic benchmark model; if narrative prose mentions different financial figures, this table is authoritative (the prose is generation-time text, while the model has been recomputed with the latest version).

Seed Returns

Seed Return Analysis

Methodology: 实现口径(现金 cash-on-cash / “拿到钱”)。失败、以及存活但未发生流动性事件的“僵尸”均计 0 实现回报;仅成功退出(并购/二级转让/回购/分红回本)计入收益。

1. Seed-round ROI by year (realized)

Holding periodCumulative ROIAnnualized return
Year 1 -68.99% -68.99%
Year 2 -43.61% -24.91%
Year 3 -22.84% -8.28%
Year 4 -5.21% -1.33%
Year 5 9.76% 1.88%
0% -69%Year 1-44%Year 2-23%Year 3-5%Year 410%Year 5

Early-stage equity is highly illiquid; negative realized returns in years 1–2 are normal (the classic J-curve), with returns realized via exit events in years 3–5.

2. Core investment metrics

21.2%
Win rate: probability of a profitable, cash-realized exit
4.19:1
Profit/loss ratio (avg win / avg loss)
1.10×
Expected MOIC (5-yr, realized)
1.9%
5-yr annualized return

3. 5-year capital outcome breakdown (why "cash realized" ≠ "paper alive")

OutcomeProbabilityRealized return to investor
Failure / liquidation27.1%≈ 0 (loss)
Alive but no liquidity event (paper-alive / zombie)40.3%≈ 0 (not realizable)
Cash exit event occurred (profitable exits 21.2%)32.6%Realized per MOIC distribution

Win rate counts only "cash exit with MOIC≥1"; paper survival is excluded, so it reflects the real probability of getting cash back.

4. Sensitivity analysis

Scenario5-yr ROI5-yr ann.Win rate
Pessimistic -41.6% -10.2% 15.1%
Base 9.8% 1.9% 21.2%
Optimistic 75.7% 11.9% 27.1%

5. Upside scenario vs. paper accounting

If exit succeeds

5.06× multiple; ~50.0% annualized (assuming exit in year 4).

Conditional "profitable exit succeeds" scenario for contrast (not an expected value; occurs with only ~21.2% probability).

Paper accounting (not used)

Year-5 survival rate ≈ 68.0%.

Paper basis: counts companies still alive in year 5 at a marked valuation as "value" — a non-cashable paper figure. Official return figures never use this basis.

Go-To-Market

Go-To-Market (GTM)

Google健康关键词广告投放

SEO内容矩阵覆盖他汀/胆固醇长尾词

与健康类KOL合作科普引流

Competition

Competition

Mayo Clinic Online — 无个性化、无AI互动,内容静态

HealthTap — 需真人医生,响应慢,成本高

WebMD — 无定制化报告,AI能力弱

Roadmap

Roadmap

MVP
  • 上线AI报告与问答,覆盖核心关键词
扩展
  • 增加药物种类与慢病管理模块
智能升级
  • 引入连续健康数据整合与个性化推送
国际化
  • 拓展多语种与欧盟市场
Team

Team & Organization

全流程AI自动化,无人工参与,合规留痕。

获客 — Google Ads+SEO自动投放(Google Ads API, SurferSEO)

交付 — OpenAI GPT-4+专有RAG模型自动生成报告

客服 — Chatbot(Dialogflow+GPT-4)全天候智能应答

收款 — Stripe API自动收款与账单管理

运维 — AWS Cloudwatch+Lambda自动监控与弹性扩容

Risks

Risks & Mitigations

RiskMitigation
AI内容误导权威医生定期复核,自动溯源标注
数据泄露端到端加密,AWS安全合规
广告获客成本上升SEO矩阵与会员复购提升LTV
法规变化法律顾问定期审核,灵活调整服务边界
The Ask

The Ask

Methodology & Sources

Methodology & Sources

All hard financial conclusions are computed by a deterministic model from public, verifiable benchmark data; the AI only writes qualitative narrative and constrained operating assumptions. Out-of-range assumptions are auto-corrected (see above). Returns always use the cash-realized basis.

  1. China startup 1-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    Over the past decade, ~92% of newly founded Chinese companies survived their first year.
  2. China startup 3-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    3-year survival ≈76.0% for 2014–2023 cohorts (annual attrition 8.2% / 9.4% / 6.4%).
  3. China startup 5-year survival (interpolated): Interpolated estimate (geometric, between y3 = 0.76 and y10 = 0.503) (2024-05) · Source link
    The report gives no direct 5-year figure; constant-hazard geometric interpolation between years 3 and 10 yields ≈67.5%, explicitly labelled an interpolated estimate.
  4. China startup 10-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    ≈50.3% of companies survive to year ten.
  5. Average Chinese SME lifespan: People’s Bank of China report (widely cited by Chinese media) (2019-06) · Source link
    Average Chinese SME lifespan ≈3 years (US ≈8 years, Japan ≈12 years).
  6. Share of VC capital realizing <1x: Correlation Ventures — “Venture Capital, We’re Still Not Normal” (2010s decade (realized)) · Source link
    ≈37% of invested capital realized <1x (a loss); by deal count, roughly half of deals lose money.
  7. Share of VC capital realizing ≥10x: Correlation Ventures (2010s decade (realized)) · Source link
    Less than 4% of invested capital realizes ≥10x (the power-law tail).
  8. VC return power law: Correlation Ventures — “The 80/20 Rule for U.S. Venture? Not Exactly.” (2010s decade) · Source link
    Returns are highly right-skewed; a small number of winners contribute most of the profits.
  9. Exit MOIC distribution (calibrated): Calibration: Correlation Ventures realized-return shape + online-asset M&A multiples (Empire Flippers / FE International / Acquire.com, 2026) (2026) · Source link
    MOIC distribution conditional on a realized cash liquidity event (M&A / secondary / buyback); upside is compressed for small online assets (rarely >25x). Bucket probabilities sum to 1.
  10. Annual exit-realization hazard (assumption): Documented assumption: median VC exits take ~5–8 years; small online assets transact faster via Acquire.com / Empire Flippers / FE International; calibrated so the cumulative 5-year exit probability ≈40% conditional on survival. (2026) · Source link
    Cumulative L(t) = 1-(1-h)^t; h = 0.097 → L(5) ≈ 0.40. Explicitly labelled an assumption and stress-tested in the sensitivity analysis.
  11. Micro-SaaS ARR multiple: CT Acquisitions / Empire Flippers / Acquire.com market observations (2026) · Source link
    Micro-SaaS (<$1M ARR) typically trades at 2.5–4x ARR.
  12. Micro-SaaS SDE multiple: FE International / Empire Flippers (2026) · Source link
    Typically 4–6x seller discretionary earnings (SDE); assets with low owner-dependency fetch the high end.
  13. Trend annualization factor (model assumption): Documented model assumption: trending interest decays in pulses; annual topic interest ≈ 30 peak-day equivalents (2026)
    Google Trends volumes are peak-day buckets; annual topic searches ≈ peak-day volume × 30. Explicitly a disclosed model assumption, bounded by the reach limits below.
  14. Capture share (model assumption): Documented model assumption: a focused niche site captures ~1% of annual topic search interest at maturity (2026)
    Derived conservatively from SERP click-share distributions (~28% at #1, ~7% at #5, <1% on page 2); modulated ±50% by data-driven persistence/intent scores.
  15. Reachable-user bounds (model constraint): Documented model constraint: year-3 reachable users are saturation-compressed into [20k, 600k] (2026)
    Lower bound = minimum viable niche audience; upper bound = realistic single-niche-site capacity ceiling. Applied via a saturating function, not a hard clamp.
  16. Zero-human fixed ops base (model assumption): Documented model assumption: hosting/compliance/model-subscription/monitoring base ramps $60k → $90k → $120k over years 1-3 (2026)
    No payroll (zero-human company); includes outsourced legal/finance and exception-handling budget.
  17. Per-active-user marginal cost (model assumption): Documented model assumption: ~$0.8 per active user per year for inference + infrastructure (2026)
    Estimated for lightweight AI workflows with caching and batching.
  18. USD/CNY exchange rate: Recent approximate CNY-per-USD rate (used for conversion; updated as needed) (2026) · Source link
    Exchange rates fluctuate; converted figures are approximations as of the stated date.
  19. Seed-round equity dilution: Industry norm: a single seed round typically dilutes 10%–20% (2026) · Source link
    Baseline 12%; used to convert enterprise-level exit value into the seed investor’s share.
  20. Early-stage venture discount rate: Early-stage VC required rates of return are typically 30%–60% (high risk premium) (2010s) · Source link
    Used for risk-adjusted discounting; baseline 35%.